These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3677696)

  • 1. Peritoneal membrane failure as a determinant of the CAPD future. An epidemiological, functional and pathological study.
    Huarte-Loza E; Selgas R; Carmona AR; Martinez ME; Muñoz J; Fontan MP; Ortega O; Escuin F; Sicilia LS
    Contrib Nephrol; 1987; 57():219-29. PubMed ID: 3677696
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis.
    Selgas R; Muñoz J; Cigarran S; Ramos P; L-Revuelta K; Escuin F; Miguel JL
    Perit Dial Int; 1989; 9(4):329-32. PubMed ID: 2577360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis E
    Adv Perit Dial; 1989; 5():8-11. PubMed ID: 2577433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal clearances, protein losses and ultrafiltration in diabetic patients after four years on CAPD.
    Coronel F; Tornero F; Macia M; Sánchez A; De Oleo P; Naranjo P; Barrientos A
    Adv Perit Dial; 1991; 7():35-8. PubMed ID: 1680453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
    Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
    Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal morphology on maintenance dialysis.
    Pollock CA; Ibels LS; Eckstein RP; Graham JC; Caterson RJ; Mahony JF; Sheil AG
    Am J Nephrol; 1989; 9(3):198-204. PubMed ID: 2667361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrate in stable CAPD patients and during peritonitis.
    Douma CE; de Waart DR; Zemel D; Imholz AL; Koomen GC; Struijk DG; Krediet RT
    Adv Perit Dial; 1995; 11():36-40. PubMed ID: 8534733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vascular endothelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis.
    Szeto CC; Wong TY; Lai KB; Chow KM; Li PK
    Perit Dial Int; 2002; 22(2):265-7. PubMed ID: 11990414
    [No Abstract]   [Full Text] [Related]  

  • 11. Peritoneal function and peritonitis in patients on peritoneal dialysis.
    Friedlander M
    J Lab Clin Med; 1993 Dec; 122(6):639-40. PubMed ID: 8245682
    [No Abstract]   [Full Text] [Related]  

  • 12. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
    Slingeneyer A; Canaud B; Mion C
    Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peritoneal function in CAPD patients].
    Suga H; Ota K
    Nihon Rinsho; 1991 Dec; 49 Suppl():484-91. PubMed ID: 1808305
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrasonographic evaluation of peritoneal membrane thickness and comparison with the effectiveness and duration of CAPD.
    Temiz G; Sahin G; Mukerrem G; Ozkurt S; Degirmenci NA; Yalcin AU
    Int Urol Nephrol; 2013 Dec; 45(6):1761-6. PubMed ID: 23884729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal permeability and encapsulating peritonitis.
    Verger C; Celicout B
    Lancet; 1985 Apr; 1(8435):986-7. PubMed ID: 2859446
    [No Abstract]   [Full Text] [Related]  

  • 16. Sclerosing encapsulating peritonitis in children.
    Niaudet P; Berard E; Revillon Y; Lothon M; Broyer M
    Contrib Nephrol; 1987; 57():230-8. PubMed ID: 3677698
    [No Abstract]   [Full Text] [Related]  

  • 17. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting changes in solute transport and ultrafiltration with peritonitis in CAPD patients.
    Raja RM; Kramer MS; Rosenbaum JL; Bolisay C; Krug M
    Trans Am Soc Artif Intern Organs; 1981; 27():68-70. PubMed ID: 7331156
    [No Abstract]   [Full Text] [Related]  

  • 19. The peritoneal membrane in chronic peritoneal dialysis.
    Krediet RT
    Kidney Int; 1999 Jan; 55(1):341-56. PubMed ID: 9893150
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity.
    Topley N; Mackenzie R; Jörres A; Coles GA; Davies M; Williams JD
    Perit Dial Int; 1993; 13 Suppl 2():S282-5. PubMed ID: 8399589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.